Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: Definitive Radiation for High-Risk Spine Metastases [Phase 2]
A Phase 2 clinical trial evaluating definitive radiation therapy for high-risk spine metastases is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Yoga for Symptoms of Nerve Damage Caused by Chemotherapy [NA]
The document reports a completed clinical trial evaluating yoga to reduce chemotherapy-induced nerve damage (peripheral neuropathy) in patie…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer [Phase 3]
A Phase 3 feasibility trial of Tele-IPT and tele-pharmacotherapy for patients with Major Depressive Disorder and non-metastatic breast cance…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Hypofractionated PBI After BCS for Low-risk Breast Cancer Patients [NA]
The trial from Fudan University evaluating hypofractionated partial-breast irradiation after breast-conserving surgery for low-risk breast c…
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias [Phase 2]
Phase 2 clinical trial evaluating cannabidiol for aromatase inhibitor-associated arthralgia in breast cancer patients has completed, with re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer [Phase 3]
Phase 3 randomized study comparing TH versus THL as first-line therapy for HER2-positive metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: Study of Elacestrant in Combination With Onapristone in Patients With Advanced or Metastatic Breast Cancer [Phase 1, Phase 2]
Clinical trial evaluating elacestrant in combination with onapristone in advanced or metastatic breast cancer has been terminated (Phase 1/P…
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP] [Phase 2]
A Phase 2 neoadjuvant trial evaluating pembrolizumab with HER2-targeted therapy for HER2-positive breast cancer, with results posted in May …
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: Trastuzumab-deruxtecan in Patients With Triple-negative Metastatic HER2-Low Breast Cancer: Real-world Experience in Brazil
A real-world study evaluating trastuzumab-deruxtecan in triple-negative metastatic HER2-low breast cancer conducted in Brazil has been termi…
-
CLINICAL_TRIALS trial_result · 2025-05-07Clinical Trial Update: 18F-fluoroestradiol (18F-FES) PET/CT Guided First-line Treatment for HR+/HER2- Metastatic Breast Cancer Patients
A clinical trial evaluating 18F-FES PET/CT guided first-line treatment for HR+/HER2- metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-07Clinical Trial Update: Topical Calcipotriene Treatment for Breast Cancer Immunoprevention [Phase 1]
Phase 1 trial evaluating topical calcipotriene for breast cancer immunoprevention has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-05-07Clinical Trial Update: Assessment of Breast Cancer Patients Satisfaction and Health Related Quality of Life Outcomes
This clinical trial update notes an active-but-not-recruiting study by Henry Ford Health System evaluating satisfaction and health-related q…
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: A Study to Evaluate Safety, Tolerability, Dosimetry, and Preliminary Efficacy of the HER2 Directed Radioligand CAM-H2 in Patients With Advanced/Metastatic HER2-Positive Breast, Gastric, and Gastro-Esophageal Junction (GEJ) Cancer [Phase 1, Phase 2]
A phase 1/2 study evaluating CAM-H2, a HER2-directed radioligand, in advanced/metastatic HER2-positive breast, gastric, and gastroesophageal…
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: Influence of Preoperative Vitamin D Level on Postoperative Pain in Breast Cancer Surgery Patients
A completed clinical trial examining whether preoperative vitamin D status affects postoperative pain after breast cancer surgery.
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: A Study of PF-07260437 in Advanced or Metastatic Solid Tumors [Phase 1]
A Phase 1 study of PF-07260437 in advanced or metastatic solid tumors was terminated, with results posted on 2025-05-06.
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: Investigation of the Effect of Erector Spinae Plane Block on Systemic Immuno-Inflammatory Index [NA]
The study NCT06954324 completed an evaluation of whether an erector spinae plane block influences the systemic immune-inflammatory index in …
-
CLINICAL_TRIALS trial_result · 2025-05-04Clinical Trial Update: Comparing Post-operative Analgesia After (PECS II) Block and (ESPB) in Modified Radical Mastectomy [NA]
A completed clinical trial comparing PECS II block vs ESPB for post-operative analgesia after modified radical mastectomy; results posted.
-
CLINICAL_TRIALS trial_result · 2025-05-04Clinical Trial Update: Sirolimus for Injection (Albumin-bound) in Combination With Endocrine Therapy for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Who Have Failed Standard Therapy [Phase 2]
Phase 2 clinical trial assessing albumin-bound sirolimus in combination with endocrine therapy for HR+/HER2- advanced/metastatic breast canc…
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Pilot Study of Anti-oxidant Supplementation With N-Acetyl Cysteine in Stage 0/I Breast Cancer [Phase 1]
This Phase 1 pilot study evaluated antioxidant N-acetylcysteine in patients with early-stage breast cancer around biopsy and prior to surger…
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: A Study of LY2880070 in Participants With Advanced or Metastatic Cancer [Phase 1, Phase 2]
Esperas Pharma completed a Phase 1/2 study of LY2880070 in adults with advanced or metastatic cancer, including colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: A Study of Effect of Megakaryocytes and Platelets in Breast Cancer
The Mayo Clinic-sponsored clinical trial evaluating the role of megakaryocytes and platelets in breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-01Clinical Trial Update: Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC) [Phase 2]
A Phase 2 trial of Taletrectinib for previously treated metastatic CDH1-mutated invasive lobular breast cancer has been suspended.
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: Cryoablation of Low Risk Small Breast Cancer- ICE3 Trial [NA]
The ICE3 trial evaluating cryoablation for low-risk small breast cancer has completed and results were posted in April 2025.
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: Supervised Physical Activity in Young Women With Early Breast Cancer During Neoadjuvant Chemotherpy [NA]
Update on a clinical trial evaluating supervised physical activity for young women with early breast cancer during neoadjuvant chemotherapy.
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: MEND 2: Making Treatment Decisions Using Genomic Testing [NA]
This clinical trial update reports that the MEND 2 study, which investigates using genomic testing to guide breast cancer treatment decision…